Is there a therapeutic window with some antidepressants for analgesic response?

Current Pain and Headache Reports

Volumn 13, Issue 2, 2009, Pages 93-99

  Atkinson, J Hampton ^a   Patel, Shetal M ^b   Meyer, Jonathan M ^b   Slater, Mark A ^b   Zisook, Sidney ^b   Capparelli, Edmund ^b  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; DESIPRAMINE; DULOXETINE; FLUOXETINE; GABAPENTIN; IMIPRAMINE; LAMOTRIGINE; MOOD STABILIZER; NORTRIPTYLINE; OXCARBAZEPINE; PAROXETINE; PLACEBO; PREGABALIN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VENLAFAXINE;

ANALGESIC ACTIVITY; BACKACHE; CHRONIC PAIN; CLINICAL TRIAL; COMORBIDITY; DIABETIC NEUROPATHY; DOSE RESPONSE; DRUG ABSORPTION; DRUG CLEARANCE; DRUG DOSE COMPARISON; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; DRUG MONITORING; DRUG RESPONSE; FIBROMYALGIA; HUMAN; ISCHIALGIA; LOW DRUG DOSE; MAJOR DEPRESSION; METHODOLOGY; NEUROPATHIC PAIN; NEUROPATHY; PAIN; PHARMACOGENETICS; POSTHERPETIC NEURALGIA; REVIEW;

ANTIDEPRESSIVE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; PAIN; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 63249128891     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-009-0018-9     Document Type: Review

References (34)

1. Watson CP, Evans RJ, Reed K, et al.: Amitriptyline versus placebo in postherpetic neuralgia. Neurology 1982, 32:671-673.
2. Max MB: Antidepressants as analgesics. In Pharmacological Approaches to the Treatment of Chronic Pain: New Concepts and Critical Issues (Progress in Pain Research and Management), vol 1. Edited by Fields HL, Liebeskind JC. Seattle: IASP Press; 1994: 229-246.
3. McQuay HJ, Derry S, Moore RA, et al.: Enriched enrolment with randomised withdrawal (EERW): Time for a new look at clinical trial design in chronic pain. Pain 2008, 135:217-220.
4. Max MB, Lynch SA, Muir J, et al.: Effects of desipramine, amitriptyline and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992, 326:1250-1256.
5. Ohayon MM, Schatzberg AF: Using chronic pain to predict depressive morbidity in the general population. Arch Gen Psychiatry 2003, 60:39-47.
6. Bair MJ, Robinson RL, Eckert GJ, et al.: Impact of pain on depression treatment response in primary care. Psychosom Med 2004, 66:17-22.
7. Ward NG, Bloom BL, Friedel RO: The effectiveness of tricyclic antidepressants in the treatment of co-existing pain and depression. Pain 1979, 7:331-341.
8. Ward NG, Bokan JA, Phillips M, et al.: Antidepressants in concomitant chronic back pain and depression: Doxepin and desipramine compared. J Clin Psychiatry 1984, 45:54-59.
9. Brannan SK, Mallinckrodt CH, Brown EB, et al.: Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder. J Psychiatr Res 2005, 39:43-53.
10. Teter CJ, Kando JC, Wells BG, et al.: Depressive disorders. In Pharmacotherapy: A Pathophysiologic Approach, edn 7. Edited by Dipiro JT. New York: McGraw Hill; 2009:1123-1140.
11. Sindrup SH, Gram LF, Skjold T, et al.: Concentration-response relationship in imipramine treatment of diabetic neuropathy symptoms. Clin Pharmacol Ther 1990, 47:509-515.
12. McQuay HJ, Carrol D, Glynn CJ: Dose-response for analgesic effect of amitriptyline in chronic pain. Anaesthesia 1993, 48:281-285.
13. Goodnick PJ: Pharmacokinetics of second generation antidepressants: fluoxetine. Psychopharmacol Bull 1991, 27:503-512.
14. Atkinson JH, Slater MA, Williams RA, et al.: A placebo-controlled randomized clinical trial of nortriptyline for chronic low back pain. Pain 1998, 76:287-296.
15. Atkinson, JH, Slater MA, Wahlgren DR, et al.: Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity. Pain 1999, 83:137-145.
16. Max MB, Culnane M, Schafer SC, et al.: Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 1987, 37:589-596.
17. Max MB, Culnane M, Schafer SC, et al.: Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology 1988, 38:1427-1432.
18. Rasmussen PV, Jensen TS, Sindrup SH, et al.: TDM-based imipramine treatment in neuropathic pain. Ther Drug Monit 2004, 26:352-360.
19. Armstrong DG, Chappell AS, Le TK, et al.: Duloxetine for the management of diabetic peripheral neuropathic pain: Evaluation of functional outcomes. Pain Med 2007, 8:410-418.
20. Arnold LM, Rosen A, Pritchett YL, et al.: A randomized, double blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain 2005, 119:5-15.
21. Pritchett YL, McCarberg BH, Watkin JG, et al.: Duloxetine for the management of diabetic peripheral neuropathic pain: Response profile. Pain Med 2007, 8:397-409.
22. Kajdasz DK, Iyengar S, Desaiah D, et al.: Duloxetine for the management of diabetic peripheral neuropathic pain: Evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies. Clin Ther 2007, 29:2536-2546.
23. Rowbotham MC, Goli V, Kunz NR, et al.: Venlafaxine extended release in the treatment of painful diabetic neuropathy: A double blind study. Pain 2004, 110:697-706.
24. Sindrup SH, Bach FW, Madsen C, et al.: Venlafaxine versus imipramine in painful polyneuropathy: A randomized trial. Neurology 2003, 60:1284-1289.
25. Kvinesdal B, Molin J, Froland A, et al.: Imipramine treatment of painful diabetic neuropathy. JAMA 1984, 251:1727-1730.
26. Max MB, Kishore-Kumar R, Schafer SC, et al.: Efficacy of desipramine in painful diabetic neuropathy: A placebo controlled trial. Pain 1991, 45:3-9.
27. Atkinson JH, Slater MA, Capparelli EV, et al.: Efficacy of noradrenergic and serotonergic antidepressants in chronic back pain: A preliminary concentration-controlled trial. J Clin Psychopharmacol 2007, 27:135-142.
28. Sindrup SH, Grodum E, Gram LF, et al.: Concentration-response relationships in paroxetine treatment of diabetic neuropathy symptoms: A patient-blind dose-escalation study. Ther Drug Monit 1991, 13:408-414.
29. Backonja M, Glanzman RL: Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials. Clin Ther 2003, 25:81-104.
30. Dworkin RH, Corbin AE, Young JP Jr, et al.: Pregabalin for the treatment of postherpetic neuralgia: A randomized, placebo-controlled trial. Neurology 2003, 60:1274-1283.
31. Lesser H, Sharma U, LaMoreaux L, et al.: Pregabalin relieves symptoms of painful diabetic neuropathy: A randomized controlled trial. Neurology 2004, 63:2104-2110.
32. Richter RW, Portenoy R, Sharma U, et al.: Relief of painful diabetic peripheral neuropathy with pregabalin: A randomized, placebo-controlled trial. J Pain 2005, 6:253-260.
33. Rice ASC, Maton S, Postherpetic Neuralgia Study Group: Gabapentin in postherpetic neuralgia: A randomized, double blind, placebo-controlled study. Pain 2001, 94:215-224.
34. Dworkin RH, O'Conner AB, Backonja M, et al.: Pharmacologic management of neuropathic pain: Evidence-based recommendations. Pain 2007, 132: 237-251.